These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 24535572)
1. An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice. Xue XH; Zheng XX; Wang HL; Ma JZ; Li L; Gai WW; Wang TC; Yang ST; Xia XZ Virus Genes; 2014 Jun; 48(3):411-20. PubMed ID: 24535572 [TBL] [Abstract][Full Text] [Related]
2. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production. Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z Virol J; 2011 Sep; 8():454. PubMed ID: 21943337 [TBL] [Abstract][Full Text] [Related]
3. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice. Liu J; Sun J; Ding X; Liu W; Wang Y; Wang Z; Peng H; Zhang Y; Su W; Jiang C Emerg Microbes Infect; 2024 Dec; 13(1):2389115. PubMed ID: 39129566 [TBL] [Abstract][Full Text] [Related]
4. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge. Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294 [TBL] [Abstract][Full Text] [Related]
5. Codon optimization of G protein enhances rabies virus-induced humoral immunity. Pei J; Huang F; Wu Q; Luo Z; Zhang Y; Ruan J; Li Y; Zhou M; Fu Z; Zhao L J Gen Virol; 2019 Aug; 100(8):1222-1233. PubMed ID: 31259681 [TBL] [Abstract][Full Text] [Related]
6. Single domain antibody multimers confer protection against rabies infection. Boruah BM; Liu D; Ye D; Gu TJ; Jiang CL; Qu M; Wright E; Wang W; He W; Liu C; Gao B PLoS One; 2013; 8(8):e71383. PubMed ID: 23977032 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein. Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075 [TBL] [Abstract][Full Text] [Related]
9. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. Ge J; Wang X; Tao L; Wen Z; Feng N; Yang S; Xia X; Yang C; Chen H; Bu Z J Virol; 2011 Aug; 85(16):8241-52. PubMed ID: 21632762 [TBL] [Abstract][Full Text] [Related]
10. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506 [TBL] [Abstract][Full Text] [Related]
11. Parainfluenza virus 5 expressing the G protein of rabies virus protects mice after rabies virus infection. Huang Y; Chen Z; Huang J; Fu Z; He B J Virol; 2015 Mar; 89(6):3427-9. PubMed ID: 25552723 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice. Kim HH; Yang DK; Nah JJ; Song JY; Cho IS Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885 [TBL] [Abstract][Full Text] [Related]
13. A single dose of recombinant adenoviral vector rabies vaccine expressing two copies of glycoprotein protects mice from lethal virus challenge. Li Q; He H; Zhou Y; Wang J; Chen H; Liu H J Infect Dev Ctries; 2024 Aug; 18(8):1281-1290. PubMed ID: 39288397 [TBL] [Abstract][Full Text] [Related]
14. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus. Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031 [TBL] [Abstract][Full Text] [Related]
15. Antigenic variations of recent street rabies virus. Wang W; Ma J; Nie J; Li J; Cao S; Wang L; Yu C; Huang W; Li Y; Yu Y; Liang M; Zirkle B; Chen XS; Li X; Kong W; Wang Y Emerg Microbes Infect; 2019; 8(1):1584-1592. PubMed ID: 31682199 [TBL] [Abstract][Full Text] [Related]
16. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice. Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572 [TBL] [Abstract][Full Text] [Related]
17. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein. Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365 [TBL] [Abstract][Full Text] [Related]
18. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells. Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066 [TBL] [Abstract][Full Text] [Related]
19. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant. Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474 [TBL] [Abstract][Full Text] [Related]
20. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice. Ramya R; Mohana Subramanian B; Sivakumar V; Senthilkumar RL; Sambasiva Rao KR; Srinivasan VA Clin Vaccine Immunol; 2011 Oct; 18(10):1673-9. PubMed ID: 21813661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]